Skip to main content

and
  1. Article

    Open Access

    A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

    Androgens have been hypothesised to influence risk of breast cancer through several possible mechanisms, including their conversion to estradiol or their binding to the oestrogen receptor and/or androgen recep...

    David G Cox, Hélène Blanché, Celeste L Pearce, Eugenia E Calle in Breast Cancer Research (2006)

  2. Article

    Open Access

    A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study

    Prostaglandins are integral components in the cellular response to inflammation, promoting cellular proliferation and angiogenesis. The enzyme responsible for the conversion of arachidonic acid to prostaglandi...

    David G Cox, Julie Buring, Susan E Hankinson, David J Hunter in Breast Cancer Research (2007)

  3. No Access

    Article

    A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

    David Hunter and colleagues report results of the CGEMS multistage genome-wide association study of breast cancer. They identify two new risk variants on chromosomes 1p11.2 and 14q24.1, and confirm several pre...

    Gilles Thomas, Kevin B Jacobs, Peter Kraft, Meredith Yeager in Nature Genetics (2009)

  4. Article

    Open Access

    A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis

    Rheumatoid arthritis (RA) is more common in females than males and sex steroid hormones may in part explain this difference. We conducted a case–control study nested within two prospective studies to determine...

    Elizabeth W Karlson, Lori B Chibnik, Monica McGrath in Arthritis Research & Therapy (2009)

  5. Article

    Open Access

    Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

    Gonadotropin releasing hormone (GNRH1) triggers the release of follicle stimulating hormone and luteinizing hormone from the pituitary. Genetic variants in the gene encoding GNRH1 or its receptor may influence...

    Federico Canzian, Rudolf Kaaks, David G Cox, Katherine D Henderson in BMC Cancer (2009)

  6. No Access

    Article

    Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

    Rachael Stolzenberg-Solomon, Laufey Amundadottir and colleagues report a genome-wide association study of pancreatic cancer. They identify four new susceptibility loci.

    Brian M Wolpin, Cosmeri Rizzato, Peter Kraft, Charles Kooperberg in Nature Genetics (2014)

  7. Article

    Open Access

    Genome-wide association study identifies multiple risk loci for renal cell carcinoma

    Previous genome-wide association studies (GWAS) have identified six risk loci for renal cell carcinoma (RCC). We conducted a meta-analysis of two new scans of 5,198 cases and 7,331 controls together with four ...

    Ghislaine Scelo, Mark P. Purdue, Kevin M. Brown, Mattias Johansson in Nature Communications (2017)

  8. Article

    Open Access

    Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

    In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer GWAS to d...

    Alison P. Klein, Brian M. Wolpin, Harvey A. Risch in Nature Communications (2018)

  9. Article

    Open Access

    A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% ...

    Evangelina López de Maturana, Juan Antonio Rodríguez, Lola Alonso in Genome Medicine (2021)